Real Progress for
Some of Dermatology’s Most Commonly Overlooked Conditions

There are far too many distressing dermatologic and aesthetic conditions without clear answers. In common conditions like pattern hair loss, innovation has lagged – leaving people underserved and clinicians without the tools they need to deliver transformative care.

Veradermics aims to change this.

LEARN MORE

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.

The company’s lead candidate under evaluation, VDPHL01, has the potential to become the first non-hormonal oral therapeutic for hair regrowth in women and men.

Read More

FEATURED NEWS

December 11, 2025

Veradermics Completes Enrollment in its Phase 2/3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss, Advancing Development of the Potential First-Ever Extended-Release Oral Minoxidil

Dermatologists Developing First-in-Class Drugs For Dermatology

Simple, Proven Care to Common Conditions Where Few Real Solutions Exist

Close-up of a woman smiling with her hand in her hair
Icon Dermatologist

BOLD STRATEGY

Advancing novel therapeutics for common conditions, to meet real-world needs that have inexplicably lacked treatment innovation, and to transform care in underserved treatment domains.

LEARN MORE
Man’s scalp with thinning hair near the crown
Icon Skin

DEEP PIPELINE

A dynamic pipeline of innovative therapies with the potential to set new standards of care – targeting first-in-class opportunities that have the potential to raise the bar on efficacy and set new benchmarks.

LEARN MORE
Clinician examining a person’s scalp with visible hair thinning
Icon Molecule

PROVEN EXPERTISE

Differentiated pipeline leveraging executive team’s front-line clinical experience as board-certified dermatologists

LEARN MORE